Published in J Biomed Nanotechnol on August 01, 2010
Sub-Optimal Treatment of Bacterial Biofilms. Antibiotics (Basel) (2016) 0.76
Recent Nanotechnology Approaches for Prevention and Treatment of Biofilm-Associated Infections on Medical Devices. Biomed Res Int (2016) 0.75
Engineering microbes to sense and eradicate Pseudomonas aeruginosa, a human pathogen. Mol Syst Biol (2011) 2.59
Sharper and faster "nano darts" kill more bacteria: a study of antibacterial activity of individually dispersed pristine single-walled carbon nanotube. ACS Nano (2009) 1.29
A predicted S-type pyocin shows a bactericidal activity against clinical Pseudomonas aeruginosa isolates through membrane damage. FEBS Lett (2010) 1.02
Reprogramming microbes to be pathogen-seeking killers. ACS Synth Biol (2013) 0.98
Vaccinia-related kinase 1 is required for the maintenance of undifferentiated spermatogonia in mouse male germ cells. PLoS One (2010) 0.95
Transporter engineering for improved tolerance against alkane biofuels in Saccharomyces cerevisiae. Biotechnol Biofuels (2013) 0.94
Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles. Colloids Surf B Biointerfaces (2011) 0.91
Microbial engineering strategies to improve cell viability for biochemical production. Biotechnol Adv (2013) 0.89
Microarray analysis of toxicogenomic effects of triclosan on Staphylococcus aureus. Appl Microbiol Biotechnol (2008) 0.88
Identification and reconstitution of genetic regulatory networks for improved microbial tolerance to isooctane. Mol Biosyst (2012) 0.86
The imminent role of protein engineering in synthetic biology. Biotechnol Adv (2011) 0.84
Transcriptome response to alkane biofuels in Saccharomyces cerevisiae: identification of efflux pumps involved in alkane tolerance. Biotechnol Biofuels (2013) 0.83
Development and characterization of AND-gate dynamic controllers with a modular synthetic GAL1 core promoter in Saccharomyces cerevisiae. Biotechnol Bioeng (2013) 0.82
Antibacterial efficacy of inhalable levofloxacin-loaded polymeric nanoparticles against E. coli biofilm cells: the effect of antibiotic release profile. Pharm Res (2010) 0.81
A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles. Int J Pharm (2011) 0.81
A predicted immunity protein confers resistance to pyocin S5 in a sensitive strain of Pseudomonas aeruginosa. Chembiochem (2013) 0.80
The absence of the luxS gene increases swimming motility and flagella synthesis in Escherichia coli K12. Biochem Biophys Res Commun (2010) 0.79
Systems-level analysis of Escherichia coli response to silver nanoparticles: the roles of anaerobic respiration in microbial resistance. Biochem Biophys Res Commun (2012) 0.79
Covalent immobilization of nisin on multi-walled carbon nanotubes: superior antimicrobial and anti-biofilm properties. Nanoscale (2011) 0.78
Biofilm-like Lactobacillus rhamnosus probiotics encapsulated in alginate and carrageenan microcapsules exhibiting enhanced thermotolerance and freeze-drying resistance. Biomacromolecules (2013) 0.78
Hollow fiber membrane decorated with Ag/MWNTs: toward effective water disinfection and biofouling control. ACS Nano (2011) 0.78
Systems-level characterization and engineering of oxidative stress tolerance in Escherichia coli under anaerobic conditions. Mol Biosyst (2012) 0.78
Antibiotic polymeric nanoparticles for biofilm-associated infection therapy. Methods Mol Biol (2014) 0.77
Therapeutic microbes for infectious disease. Methods Mol Biol (2014) 0.77
Strain improvement and process development for biobutanol production. Recent Pat Biotechnol (2009) 0.76
A simple and effective plating method to screen polycyclic aromatic hydrocarbon-degrading bacteria under various redox conditions. Appl Microbiol Biotechnol (2010) 0.76
Self-assembled amorphous drug-polyelectrolyte nanoparticle complex with enhanced dissolution rate and saturation solubility. J Colloid Interface Sci (2011) 0.76
Bacterial XylRs and synthetic promoters function as genetically encoded xylose biosensors in Saccharomyces cerevisiae. Biotechnol J (2014) 0.76
Green amorphous nanoplex as a new supersaturating drug delivery system. Langmuir (2012) 0.75
Green preparation of antibiotic nanoparticle complex as potential anti-biofilm therapeutics via self-assembly amphiphile-polyelectrolyte complexation with dextran sulfate. Colloids Surf B Biointerfaces (2011) 0.75
Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants. Int J Pharm (2010) 0.75
Improvement of biomass properties by pretreatment with ionic liquids for bioconversion process. Bioresour Technol (2012) 0.75
A highly sustainable and versatile granulation method of nanodrugs via their electrostatic adsorption onto chitosan microparticles as the granulation substrates. Int J Pharm (2013) 0.75
Dry powder inhaler formulation of lipid-polymer hybrid nanoparticles via electrostatically-driven nanoparticle assembly onto microscale carrier particles. Int J Pharm (2012) 0.75
A time-course transcriptome analysis of Escherichia coli with direct electrochemistry behavior in microbial fuel cells. Chem Commun (Camb) (2009) 0.75
Amorphization strategy affects the stability and supersaturation profile of amorphous drug nanoparticles. Mol Pharm (2014) 0.75
Towards sustainability: new approaches to nano-drug preparation. Curr Pharm Des (2013) 0.75